Exhale

The official blog of the Lung Institute.

Is Silicosis Fatal?

Is Silicosis Fatal?

Yes, silicosis can be fatal. This respiratory disease is caused by inhaling crystalline silica dust, which produces inflammation and scarring when it settles into the lungs. As time passes, this scarring causes the lungs to stiffen. Silicosis is associated with various symptoms that tend to worsen over time, the most common of which include coughing,…

Read More >

How Does Emphysema Affect Lung Function?

How Does Emphysema Affect Lung Function?

Emphysema affects lung function in three main ways. First, emphysema causes holes to gradually form inside the lungs’ air sacs, thereby weakening their internal structure and inhibiting the exchange of oxygen and carbon dioxide. Second, emphysema damages the elasticity of the airways that lead to the air sacs, causing the air sacs to collapse and…

Read More >

What Medications are Prescribed for COPD?

What medications are prescribed for COPD?

The medications prescribed for chronic obstructive pulmonary disease (COPD) depend on the type of symptoms that a patient is experiencing, as well as their frequency and severity. COPD, which is a category of diseases including emphysema and chronic bronchitis, is characterized by restricted airflow into and out of the lungs, resulting in shortness of breath…

Read More >

The Future of Regenerative Medicine

The Future of Regenerative Medicine

The Future of Regenerative Medicine is bright, and more promising all the time. Future breakthroughs in regenerative medicine promise the ability to regrow tissue to cure disease or repair damaged organs by harnessing the ability of cells to assume the form and function of any type of cell in the body.

Read More >

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.